To determine whether the B cell‐intrinsic MIF pathway is differentially regulated in early MS, we assessed the expression levels of MIF receptors CXCR4 and CD74 on blood B cells of relapsing‐remitting MS (RRMS) patients and healthy controls (HC). Here, CD74 is linked to myeloid sarcoma.